•
Mar 31, 2024

Sanara MedTech Q1 2024 Earnings Report

Sanara MedTech reported tenth consecutive record revenue quarter, with increased sales of soft tissue repair products.

Key Takeaways

Sanara MedTech Inc. announced its Q1 2024 results, achieving a record revenue quarter with $18.5 million in net revenue, a 19% increase year-over-year. However, the company reported a net loss of $1.8 million, compared to a net loss of $1.2 million in the same quarter of the previous year.

Sanara MedTech achieved its tenth consecutive record revenue quarter.

Net revenue for Q1 2024 was $18.5 million, a 19% increase compared to Q1 2023.

The company reported a net loss of $1.8 million for Q1 2024, compared to a net loss of $1.2 million for Q1 2023.

Adjusted EBITDA for Q1 2024 was $0.3 million, compared to negative Adjusted EBITDA of $0.3 million for the same period last year.

Total Revenue
$18.5M
Previous year: $15.5M
+19.4%
EPS
-$0.21
Previous year: -$0.14
+50.0%
Gross Profit
$15.5M
Previous year: $13.4M
+16.0%
Cash and Equivalents
$2.83M
Previous year: $7.29M
-61.2%
Free Cash Flow
-$1.66M
Previous year: -$1.77M
-6.2%
Total Assets
$70.9M
Previous year: $60M
+18.3%

Sanara MedTech

Sanara MedTech